Lake RA - Search Results

1

Tumor Infiltrating Effector Memory Antigen-Specific CD8⁺ T Cells Predict Response to Immune Checkpoint Therapy.

Principe N, Kidman J, Goh S, Tilsed CM, Fisher SA, Fear VS, Forbes CA, Zemek RM, Chopra A, Watson M, Dick IM, Boon L, Holt RA, Lake RA, Nowak AK, Lesterhuis WJ, McDonnell AM, Chee J. Principe N, et al. Among authors: lake ra. Front Immunol. 2020 Nov 12;11:584423. doi: 10.3389/fimmu.2020.584423. eCollection 2020. Front Immunol. 2020. PMID: 33262762 Free PMC article.

2

T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.

Marzo AL, Lake RA, Robinson BW, Scott B. Marzo AL, et al. Among authors: lake ra. Cancer Res. 1999 Mar 1;59(5):1071-9. Cancer Res. 1999. PMID: 10070965

3

Tumor antigens are constitutively presented in the draining lymph nodes.

Marzo AL, Lake RA, Lo D, Sherman L, McWilliam A, Nelson D, Robinson BW, Scott B. Marzo AL, et al. Among authors: lake ra. J Immunol. 1999 May 15;162(10):5838-45. J Immunol. 1999. PMID: 10229818

4

Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.

Robinson BW, Lake RA, Nelson DJ, Scott BA, Marzo AL. Robinson BW, et al. Among authors: lake ra. Immunol Cell Biol. 1999 Dec;77(6):552-8. doi: 10.1046/j.1440-1711.1999.00876.x. Immunol Cell Biol. 1999. PMID: 10571677 Review.

5

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.

Marzo AL, Kinnear BF, Lake RA, Frelinger JJ, Collins EJ, Robinson BW, Scott B. Marzo AL, et al. Among authors: lake ra. J Immunol. 2000 Dec 1;165(11):6047-55. doi: 10.4049/jimmunol.165.11.6047. J Immunol. 2000. PMID: 11086036

6

Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor tolerance.

Robinson BW, Scott BM, Lake RA, Stumbles PA, Nelson DJ, Fisher S, Marzo AL. Robinson BW, et al. Among authors: lake ra. Clin Cancer Res. 2001 Mar;7(3 Suppl):811s-817s. Clin Cancer Res. 2001. PMID: 11300477

7

New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.

Nowak AK, Lake RA, Kindler HL, Robinson BW. Nowak AK, et al. Among authors: lake ra. Semin Oncol. 2002 Feb;29(1):82-96. doi: 10.1053/sonc.2002.30234. Semin Oncol. 2002. PMID: 11836673 Review.

8

Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy.

Nowak AK, Robinson BW, Lake RA. Nowak AK, et al. Among authors: lake ra. Cancer Res. 2002 Apr 15;62(8):2353-8. Cancer Res. 2002. PMID: 11956096

9

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells.

Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, Frelinger JA, Robinson BW. Nowak AK, et al. Among authors: lake ra. J Immunol. 2003 May 15;170(10):4905-13. doi: 10.4049/jimmunol.170.10.4905. J Immunol. 2003. PMID: 12734333

10

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.

Nowak AK, Robinson BW, Lake RA. Nowak AK, et al. Among authors: lake ra. Cancer Res. 2003 Aug 1;63(15):4490-6. Cancer Res. 2003. PMID: 12907622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters